{"filing":{"accession_number":"0000899923-26-000079","cik":"0000899923","ticker":"MYGN","company_name":"MYRIAD GENETICS INC","form":"8-K","filing_date":"2026-09-16","report_date":"2026-09-15","primary_document":"mygn-20260915.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/899923/000089992326000079/mygn-20260915.htm"},"events":[{"id":33781,"run_id":31082,"accession_number":"0000899923-26-000079","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Vishal Sikri was appointed Executive Vice President, Commercial, effective September 16, 2026, following his promotion from Senior Vice President, Product. The appointment was announced via press release and represents a key leadership transition in the company's commercial organization.","company_name":"MYRIAD GENETICS INC","ticker":"MYGN","filing_date":"2026-09-16","form":"8-K","submitted_at":null,"items":[{"id":37308,"accession_number":"0000899923-26-000079","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing discloses the appointment of Vishal Sikri as Executive Vice President, Commercial, effective September 16, 2026, following his promotion from Senior Vice President, Product. While the section also mentions Brian Donnelly's departure as Chief Commercial Officer, the principal action emphasized in both the 8-K and press release is Sikri's appointment to lead the commercial organization. The CEO's statement highlights Sikri's qualifications and strategic importance to executing the company's growth strategy, making the appointment the salient event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-16T12:03:04.912025+00:00","company_name":"","ticker":null,"filing_date":""},{"id":37309,"accession_number":"0000899923-26-000079","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing announces Vishal Sikri's promotion to Executive Vice President - Commercial, effective September 16, 2026, as the principal disclosed action. While Brian Donnelly's departure as Chief Commercial Officer is also mentioned, the press release centers on Sikri's appointment and his qualifications to lead the commercial organization. The appointment of a named executive to a senior leadership role is material to investors assessing management capability and strategic execution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-16T12:03:04.912025+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":37308,"accession_number":"0000899923-26-000079","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing discloses the appointment of Vishal Sikri as Executive Vice President, Commercial, effective September 16, 2026, following his promotion from Senior Vice President, Product. While the section also mentions Brian Donnelly's departure as Chief Commercial Officer, the principal action emphasized in both the 8-K and press release is Sikri's appointment to lead the commercial organization. The CEO's statement highlights Sikri's qualifications and strategic importance to executing the company's growth strategy, making the appointment the salient event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-16T12:03:04.912025+00:00","company_name":"MYRIAD GENETICS INC","ticker":"MYGN","filing_date":"2026-09-16"},{"id":37309,"accession_number":"0000899923-26-000079","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing announces Vishal Sikri's promotion to Executive Vice President - Commercial, effective September 16, 2026, as the principal disclosed action. While Brian Donnelly's departure as Chief Commercial Officer is also mentioned, the press release centers on Sikri's appointment and his qualifications to lead the commercial organization. The appointment of a named executive to a senior leadership role is material to investors assessing management capability and strategic execution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-16T12:03:04.912025+00:00","company_name":"MYRIAD GENETICS INC","ticker":"MYGN","filing_date":"2026-09-16"}]}